Invacare Co. (NYSE:IVC) has earned a consensus recommendation of “Hold” from the six research firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have given a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $16.00.
A number of research analysts have issued reports on the stock. ValuEngine raised shares of Invacare from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st. KeyCorp reissued a “buy” rating and set a $20.00 target price on shares of Invacare in a research note on Thursday, December 21st. Finally, Zacks Investment Research lowered shares of Invacare from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th.
Shares of Invacare (NYSE IVC) opened at $16.65 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.57 and a current ratio of 2.28. Invacare has a 1 year low of $9.90 and a 1 year high of $17.95. The firm has a market cap of $547.29, a PE ratio of -7.12 and a beta of 2.45.
The company also recently announced a quarterly dividend, which was paid on Tuesday, January 16th. Shareholders of record on Thursday, January 4th were paid a dividend of $0.0125 per share. This represents a $0.05 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend was Wednesday, January 3rd. Invacare’s payout ratio is -2.14%.
A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in Invacare by 3.8% during the 2nd quarter. Vanguard Group Inc. now owns 2,934,593 shares of the health services provider’s stock valued at $38,736,000 after purchasing an additional 107,359 shares during the period. Barrow Hanley Mewhinney & Strauss LLC lifted its stake in shares of Invacare by 654.1% in the 3rd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 2,383,222 shares of the health services provider’s stock worth $37,535,000 after acquiring an additional 2,067,186 shares during the period. Royce & Associates LP lifted its stake in shares of Invacare by 4.4% in the 3rd quarter. Royce & Associates LP now owns 1,414,169 shares of the health services provider’s stock worth $22,273,000 after acquiring an additional 59,430 shares during the period. Northpointe Capital LLC lifted its stake in shares of Invacare by 96.8% in the 3rd quarter. Northpointe Capital LLC now owns 1,151,700 shares of the health services provider’s stock worth $18,139,000 after acquiring an additional 566,574 shares during the period. Finally, Elk Creek Partners LLC lifted its stake in shares of Invacare by 17.5% in the 3rd quarter. Elk Creek Partners LLC now owns 869,081 shares of the health services provider’s stock worth $13,688,000 after acquiring an additional 129,676 shares during the period.
TRADEMARK VIOLATION WARNING: This piece of content was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/19/invacare-co-ivc-receives-average-rating-of-hold-from-brokerages.html.
Invacare Company Profile
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.